ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,936Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 11

$2.12M Total Retail Price of All Prescriptions

Rank: 1 out of 11

773 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 773 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 773 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 23,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,501 1,031 S3 1 1
LEVOTHYROXINE SODIUM 1,261 1,064 2 2
LISINOPRIL 902 662 3 4
OMEPRAZOLE 676 493 4 3
GABAPENTIN 664 416 5 8
LOVAZA 598 477 6 47
FUROSEMIDE 573 463 7 5
AMLODIPINE BESYLATE 542 442 8 6
PRAVASTATIN SODIUM 507 381 9 19
METOPROLOL TARTRATE 503 427 10 7
SIMVASTATIN 485 361 11 9
ATORVASTATIN CALCIUM 462 342 12 13
CARVEDILOL 404 371 13 16
CRESTOR 384 272 14 27
CITALOPRAM HBR 369 307 15 15
WARFARIN SODIUM 364 275 16 11
LOSARTAN POTASSIUM 353 273 17 21
NEXIUM 328 203 18 31
MELOXICAM 326 157 19 43
METOPROLOL SUCCINATE 324 268 20 25
ZOLPIDEM TARTRATE 315 178 21 23
ATENOLOL 292 249 22 29
DONEPEZIL HCL 283 274 23 12
SODIUM CHLORIDE 283 128 10 23 70
POTASSIUM CHLORIDE 282 225 25 10
CLOPIDOGREL 281 230 26 30
PANTOPRAZOLE SODIUM 255 220 27 36
BUSPIRONE HCL 251 181 28 56
POLYETHYLENE GLYCOL 3350 249 202 29 14
METFORMIN HCL 242 128 30 17
LYRICA 242 140 30 74
CLONIDINE HCL 235 164 32 46
FENOFIBRATE 227 137 33 54
RANITIDINE HCL 212 163 34 27
ISOSORBIDE MONONITRATE ER 200 183 35 33
HYDRALAZINE HCL 196 175 36 45
PLAVIX 195 169 37 42
METFORMIN HCL ER 192 120 38 109
LIDODERM 182 164 39 24
DIOVAN 181 151 40 49
CEFDINIR 178 132 41 104
CELEBREX 178 142 41 93
PROMETHAZINE HCL 177 130 R 43 57
SPIRONOLACTONE 175 129 44 63
SINGULAIR 172 63 45 65
ROPINIROLE HCL 171 125 46 77
NAMENDA 167 167 47 18
TRICOR 166 85 48 89
LEVETIRACETAM 161 111 49 44
NOVOLOG 159 114 50 80
ZETIA 155 83 51 85
SPIRIVA 155 114 51 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 152 94 53 75
AZITHROMYCIN 147 94 54 62
MIRTAZAPINE 145 119 55 22
SERTRALINE HCL 144 94 56 20
MONTELUKAST SODIUM 143 65 57 95
TRAMADOL HCL 142 112 58 35
NITROGLYCERIN PATCH 141 141 59 87
ALENDRONATE SODIUM 139 125 60 71
RISPERIDONE 133 116 61 69
HYDROCHLOROTHIAZIDE 132 84 62 32
ESCITALOPRAM OXALATE 125 73 63 60
SYNTHROID 125 90 63 82
TRAZODONE HCL 124 86 65 38
ENDOCET 124 42 S2 65 147
DIGOXIN 122 105 67 58
CIPROFLOXACIN HCL 121 101 68 86
TAMSULOSIN HCL 119 96 69 55
NYSTATIN 119 94 69 52
LIDOCAINE HCL 118 113 71 114
IPRATROPIUM-ALBUTEROL 118 107 71 53
JANTOVEN 116 114 73 120
EXELON 114 114 74 37
JANUVIA 114 108 74 84
ALLOPURINOL 107 79 76 41
TEKTURNA 104 89 77 158
LANTUS 104 90 77 34
DIOVAN HCT 102 58 79 129
NIFEDIPINE ER 102 89 79 160
PAROXETINE HCL 101 73 81 78
NASONEX 98 65 82 162
LEVEMIR 97 94 83 133
SYMBICORT 97 76 83 117
PROAIR HFA 97 47 83 83
QUETIAPINE FUMARATE 95 68 86 50
DEXILANT 93 75 87 165
LIPITOR 92 71 88 81
TRILIPIX 92 46 88 96
IBUPROFEN 87 37 90 168
DOXYCYCLINE HYCLATE 86 61 91 170
LANSOPRAZOLE 85 55 92 140
MECLIZINE HCL 85 80 92 123
COMBIVENT 84 31 94 106
CEFTRIAXONE 83 79 95 141
MUPIROCIN 83 73 95 61
PRADAXA 82 73 97 121
GLIPIZIDE 81 53 98 51
INSULIN SYRINGE 78 47 99 90
CARBIDOPA-LEVODOPA 78 59 99 79
ONDANSETRON HCL 76 46 101 179
ADVAIR DISKUS 76 29 101 73
DICYCLOMINE HCL 75 40 103 180
TRIAMCINOLONE ACETONIDE 75 61 103 180
ENALAPRIL MALEATE 74 57 105 182
CYCLOBENZAPRINE HCL 73 38 R 106 67
FLUTICASONE PROPIONATE 73 38 106 38
JANUMET 73 50 106 144
FLECTOR 71 71 109 184
NATEGLINIDE 69 67 110 189
LACTULOSE 68 53 111 26
FLUCONAZOLE 68 46 111 190
FLUOXETINE HCL 66 39 113 92
HYDROXYZINE PAMOATE 66 35 R 113 94
TIZANIDINE HCL 65 13 115 101
PRANDIN 65 56 115 193
CYMBALTA 65 50 115 40
KLOR-CON M20 65 52 115 64
ACTOS 64 49 119 194
THEOPHYLLINE ANHYDROUS 64 44 119 194
DIVALPROEX SODIUM 64 58 119 48
LOSARTAN-HYDROCHLOROTHIAZIDE 64 54 119 88
ABILIFY 63 18 123 150
PRIMIDONE 63 31 123 152
ISOSORBIDE DINITRATE 62 59 125 197
XARELTO 61 55 126 201
MEGESTROL ACETATE 59 55 R 127 131
AMITRIPTYLINE HCL 59 34 R 127 76
BYSTOLIC 59 40 127 137
VITAMIN D2 59 53 127 155
PEN NEEDLE 58 43 131 147
DILTIAZEM HCL 56 43 132 209
FORTEO 56 55 132 209
FENTANYL 56 40 S2 132 59
BUMETANIDE 55 52 135 72
FEXOFENADINE HCL 55 27 135 211
PREDNISONE 53 36 137 68
NITROSTAT 53 42 137 153
FAMOTIDINE 52 36 139 105
BACLOFEN 51 16 140 145
AMLODIPINE BESYLATE-BENAZEPRIL 51 40 140 218
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.